
Drugmakers scramble for the next obesity-drug wave after Novo Nordisk and Eli Lilly dominate
As leaders lock in GLP-1 momentum, challengers race to prove they can earn a place in the market.

Curating from trusted global sources…
Curated from trusted global sources, refined into briefing-grade analysis with executive summaries, insights, and bullet-point takeaways.

As leaders lock in GLP-1 momentum, challengers race to prove they can earn a place in the market.

Rivian CEO RJ Scaringe built Mind Robotics late last year and says it has raised over $1 billion, signaling a new robotics bet.

Disney wants higher shipping velocity from AI, but it is drawing a hard line against token waste.

The Wembley residency kicks off June 12 with a tribute on the big screens and a plan to break the stadium record.

Her Giving Pledge advice lands as SpaceX, OpenAI, and Anthropic prepare to create a fresh wave of ultra-wealth.

The $20B AI search firm founder explains how “sleeping with that fear” becomes a strategy, not a shutdown button.

A columnist warns that mega tech listings are pushing shares to levels that strain reality and discipline.
The bank spent SAR 122.55 million at SAR 24.51 per share to secure treasury stock for employee incentives.

As SpaceX’s IPO reshaped wealth for thousands and CFO work for the next era, Johnsen’s role becomes the template.

An AI cloud upstart makes the index faster than investors can finish recalculating what it actually is.

Antares’ microreactor milestone collides with a uranium supply chain gap, with Russia enrichment and long-lead mines in the way.

The debut’s math says AI is the main engine, and investors just raised the performance bar for years.